Alvotech ALVO
NASDAQ ALVO
$5.32 -0.06 (-1.12%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alvotech (ALVO) Non Operating Interest Expenses (2021 - 2026)

Alvotech's (ALVO) quarterly Non Operating Interest Expenses came in at -$41.0 million in Q2 2026, down 11.93% on a YoY basis from -$46.6 million in Q2 2025, and down 0.53% quarter-over-quarter from -$40.8 million in Q1 2026.

Analysis

Alvotech (ALVO) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Non Operating Interest Expenses for 6 consecutive years, with -$41.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Interest Expenses fell 11.93% year-over-year to -$41.0 million; the trailing twelve-month figure through Jun 2026 stood at -$319.5 million (up 4.8% YoY), and the FY2025 full-year result was -$149.2 million, up 50.79% from the prior year.
  • Non Operating Interest Expenses eased to -$41.0 million in Q2 2026 per ALVO's latest filing, from -$40.8 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at $240.8 million in Q2 2022 and bottomed at -$303.2 million in Q4 2024.
  • Historically, Non Operating Interest Expenses has averaged -$87.6 million across 5 years, with a median of -$68.2 million in 2023.
  • The widest YoY moves for Non Operating Interest Expenses: up 80.69% in 2025, down 516.53% in 2025.
  • Over 5 years, Non Operating Interest Expenses stood at -$188.4 million in 2022, then slumped by 41.79% to -$267.2 million in 2023, then declined by 13.48% to -$303.2 million in 2024, then surged by 76.19% to -$72.2 million in 2025, then jumped by 43.17% to -$41.0 million in 2026.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$41.0 million, -$40.8 million, and -$72.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 120.70 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -13.26 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 396.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn -
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -41.02 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 6.66 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 3,000.00
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 4,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.02 Mn
Mar 31, 2026 -40.81 Mn
Dec 31, 2025 -72.19 Mn
Sep 30, 2025 -165.49 Mn
Jun 30, 2025 -36.65 Mn
Mar 31, 2025 -35.54 Mn
Dec 31, 2024 -303.17 Mn
Sep 30, 2024 39.73 Mn
Jun 30, 2024 -93.35 Mn
Mar 31, 2024 -184.06 Mn
Dec 31, 2023 -267.16 Mn
Aug 31, 2023 -64.30 Mn
Jun 30, 2023 143.30 Mn
Mar 20, 2023 -267.16 Mn
Dec 31, 2022 -188.42 Mn
Aug 31, 2022 -52.41 Mn
Jun 30, 2022 240.83 Mn
Mar 20, 2022 -188.42 Mn
Dec 31, 2021 -117.36 Mn
Sep 30, 2021 -33.78 Mn